Chronic Lymphocytic Leukemia

Approaches to Individualized Treatment for Chronic Lymphocytic Leukemia: Expert Guidance on Sequencing Therapy, Novel Agents, and their Combinations

The goal of this program is to improve the knowledge and competence of clinicians to implement best practices in the treatment of CLL.

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC

NCCN Guidelines® Insights - Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019

These NCCN Guidelines Insights discuss the recommendations for the diagnosis and management of patients with histologic transformation.

Recorded Presentation from the NCCN Pharmacy Updates: New Therapies for Chronic Lymphocytic Leukemia and a Changing Treatment Paradigm

Join Emily K. Dotson, PharmD, BCOP, from The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute for this webinar in the 2018 NCCN Pharmacy Update Series on the topic New Therapies for Chronic Lymphocytic Leukemia and a Changing Treatment Paradigm.

Updates in the Management of CLL: Histologic Transformation and Relapsed/Refractory Disease

Histologic transformation of chronic lymphocytic leukemia (CLL) to more aggressive lymphoma is associated with a poor prognosis since it is typically resistant to standard chemoimmunotherapy regimens used for the treatment of CLL.

NCCN Pharmacy Updates: New Therapies for Chronic Lymphocytic Leukemia and a Changing Treatment Paradigm

Join Emily K.

Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Chronic Lymphocytic Leukemia (CLL)

Join Jennifer Brown, MD, PhD, and Matthew Davids, MD, MMSc, from Dana-Farber Cancer Institute as they present their multidisciplinary expertise on a range of cases pertaining to chronic lymphocytic leukemia (CLL).

Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Chronic Lymphocytic Leukemia (CLL)

Join Jennifer Brown, MD, PhD, and Matthew Davids, MD, MMSc, from Dana-Farber Cancer Institute as they present their multidisciplinary expertise on a range of cases pertaining to chronic lymphocytic leukemia (CLL).

How to Sequence Therapy in Chronic Lymphocytic Leukemia

This information was originally presented at the NCCN 12th Annual Congress: Hematologic Malignancies™ held in San Francisco, California, on October 6-7, 2017.

Recorded Presentation from the NCCN 2017 Nursing Program Webinar Series - Clinical Updates and Issues: Chronic Lymphocytic Lymphoma

The 2017 NCCN Nursing Program: Advancing Oncology Nursing Live Webinar Series will provide oncology nurses with comprehensive and clinically relevant information to optimize patient education and care.

NCCN 2017 Nursing Program Webinar Series - Clinical Updates and Issues: Chronic Lymphocytic Lymphoma